TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Q3 2025 Earnings Call Transcript
TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Q3 2025 Earnings Call Transcript November 13, 2025TriSalus Life Sciences, Inc. misses on earnings expectations.
Trisalus Life Sciences Inc. (TLSI)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Nantahala Capital Management Wilmot B. Harkey And Daniel Mack | 2,040,245 | $9,487,139 | +3% | 0.33% |
| 2. | Alyeska Investment Group Anand Parekh | 557,500 | $2,592,375 | 0.01% | |
| 3. | Squarepoint Ops LLC Maxime Fortin (Cio) | 73,706 | $342,733 | 0% | |
| 4. | 126,876 | $199,195 | +439% | 0% | |
| 5. | MSDC Management Marc Lisker, Glenn Fuhrman And John Phelan | 39,999 | $185,995 | 0.12% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.65 | 6,000 | $33,900.00 | 30,000 | 2025-02-05 | Filing | |
| $5.28 | 5,010 | $26,452.80 | 444,259 | 2025-01-30 | Filing | |
| $5.03 | 5,030 | $25,300.90 | 439,249 | 2025-01-29 | Filing | |
| $5.12 | 4,716 | $24,145.92 | 434,219 | 2025-01-28 | Filing | |
| $5.42 | 4,826 | $26,156.92 | 429,503 | 2025-01-27 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.18 | 4,764 | $24,677.52 | 119,415 | 2025-05-19 | Filing | |
| $5.18 | 4,764 | $24,677.52 | 52,764 | 2025-05-19 | Filing | |
| $5.18 | 6,597 | $34,172.46 | 69,101 | 2025-05-19 | Filing | |
| $5.18 | 8,704 | $45,086.72 | 77,640 | 2025-05-19 | Filing | |
| $4.44 | 314 | $1,394.16 | 86,382 | 2024-10-05 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,250,000 | $5,812,500 | 0.54% | |
| 2. | 1,159,575 | $5,392,024 | 0% | |
| 3. | 1,047,059 | $4,868,824 | 0.05% | |
| 4. | 787,864 | $3,663,568 | 0% | |
| 5. | 643,740 | $2,993,391 | 0.06% |
News See All
TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Q2 2025 Earnings Call Transcript
TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Q2 2025 Earnings Call Transcript August 12, 2025TriSalus Life Sciences, Inc. misses on earnings expectations.
TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Q1 2025 Earnings Call Transcript
TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Q1 2025 Earnings Call Transcript May 15, 2025TriSalus Life Sciences, Inc. misses on earnings expectations.
TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Q4 2024 Earnings Call Transcript
TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Q4 2024 Earnings Call Transcript March 27, 2025TriSalus Life Sciences, Inc. reports earnings inline with expectations.
TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Q3 2024 Earnings Call Transcript
TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Q3 2024 Earnings Call Transcript November 14, 2024TriSalus Life Sciences, Inc. misses on earnings expectations.
TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Q2 2024 Earnings Call Transcript
Operator: Good morning, and welcome to TriSalus Science Second Quarter 2024 Earnings Conference Call. Currently, all participants are on listen-only mode.
TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Q1 2024 Earnings Call Transcript
Operator: Good morning. And welcome to TriSalus Life Sciences First Quarter 2024 Earnings Conference Call. Currently, all participants are on a listen-only mode.
TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Q4 2023 Earnings Call Transcript
Operator: Good morning. And welcome to TriSalus Life Sciences Fourth Quarter and Full Year 2023 Earnings Conference Call. Currently, all participants are on a listen-only mode.